Trial Profile
1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/tiotropium bromide (Primary) ; Salmeterol; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 30 Sep 2021 This trial has been completed in France (End Date: 21 Nov 2008), according to European Clinical Trials Database record.
- 04 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database.
- 28 Apr 2012 Planned number of patients changed from 205 to 1800 as reported by European Clinical Trials Database record.